[ep″e-roo´bĭ-sin] an antitumor antibiotic of the anthracycline group, having the same actions as doxorubicin but a lower toxicity; administered intravenously in the treatment of carcinoma of the breast, ovary, stomach, colon, and rectum, as well as leukemia, lymphoma, and multiple myeloma.
epirubicin
A CYTOTOXIC anti-cancer drug. A brand name is Pharmorubicin.